Temasek’s SeaTown to invest up to S$115 million in Singapore healthcare firm AddVita
Investment brings alternative investor close to full deployment of its US$1 billion-plus private capital fund
Add BT as a preferred source
[SINGAPORE] SeaTown Holdings, an investment manager indirectly owned by Temasek, said on Wednesday (May 21) it is committing up to S$115 million in Singapore healthcare and life sciences firm AddVita.
Offering medical and laboratory technologies, AddVita sells pharmaceutical products as well, to hospitals, clinics, pharmacies and healthcare providers throughout Asia, particularly South-east Asia.
It also buys companies, focusing on small and medium-sized distributors in the healthcare and life sciences sectors, using the so-called buy-and-build strategy.
TRENDING NOW
Think twice about rebuilding that old landed property into a super-big house to max out GFA
SpaceX’s US$1.75 trillion IPO: How retail investors, including those in Singapore, can buy shares
Battle for Asia’s ultra-rich: ‘Singapore can’t afford to keep losing clients to Dubai, Hong Kong’
Tech rout sweeps Asia as AI rally jitters spark sell-off
